CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 400,000 shares at an average $5.75 ($2,298,600)
- 4 Open-market buy 10% owner bought 300,000 shares at $5.96 ($1,788,180)
- 4 Exercise or conversion Chief Operating Officer acquired 8,500 shares (option exercise)
- 4 Open-market buy 10% owner bought 500,000 shares at an average $4.50 ($2,247,600)
- 4 Open-market buy 10% owner bought 454,399 shares at an average $3.89 ($1,767,484)
- 4 Open-market buy SVP, CFO and Secretary bought 40,000 shares at $2.47 ($98,800)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Sr VP, Research & CSO gave up 1,666 shares (to pay taxes)
- 4 Exercise or conversion President and CEO acquired 53,265 shares (option exercise)
- 4 Exercise or conversion SVP, CFO and Secretary acquired 8,316 shares (option exercise)
- 4 Exercise or conversion Chief Operating Officer acquired 500 shares (option exercise)
Page 8 of 25 · 484 filings